What the Evidence Shows and What It Does Not MedicalDaily Evidence Check Data source: Multiple peer-reviewed studies published 2025-2026, including British Journal of Pharmacology, Nature Reviews Endocrinology, and body composition literature on STEP and SURMOUNT trial data Key finding: Up to 40% of weight lost on high-efficacy GLP-1 drugs is lean body mass
Jeff Giullian, chief medical officer for DaVita, said at the time, adding, Based on the inclusion criteria for study participants, we believe there may be limited application of the FLOW study findings to the overall CKD patient population. He argued that the inclusion requirements necessary to partake in the FLOW trial, such as needing to be on a standard kidney disease treatment and have a certain amount of protein in the urine, were attributable to a narrow subset less than 10% of all current CKD patients
It is administered by injection, in doses that start small and gradually increase in a bid to reduce side effects (which can be severe)
Here are some good choices: Avocados Nuts and seeds (almonds, walnuts, chia seeds) Olive oil Yogurt Power: Yogurt can be a fantastic source of protein and calcium
